Poly(ADP-ribosyl)ation and stroke

Pharmacological Research

Volumn 52, Issue 1 SPEC. ISS., 2005, Pages 15-24

  Chiarugi, Alberto ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cerebral ischemia; Gene expression; Neuroprotection; PARG; PARP; Poly(ADP ribose)

Indexed keywords

1,11B DIHYDRO (2H) BENZOPYRANO[4,3,2 DE]ISOQUINOLIN 3 ONE; 2 METHYL 3,5,7,8 TETRAHYDROTHIOPYRANO[4,3 D]PYRIMIDIN 4 ONE; 3 AMINOBENZAMIDE; 3,4 DIHYDRO 5 [4 (1 PIPERIDINYL)BUTOXY] 1(2H) ISOQUINOLINONE; 5 CHLORO 2 [3 (4 PHENYL 3,6 DIHYDRO 1(2H) PYRIDINYL)PROPYL] 4(3H) QUINAZOLINONE; AZA 5(H) PHENANTHRIDIN 6 ONE; DR 2313; FR 247304; GPI 6150; INDENOISOQUINOLINONE; INO 1001; N (5,6 DIHYDRO 6 OXO 2 PHENANTHRIDINYL) 2 DIMETHYLAMINOACETAMIDE; N (6 OXO 5,6 DIHYDROPHENANTHRIDIN 2 YL) N,N DIMETHYLACETAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1 INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PHENANTHRIDINE DERIVATIVE; THIENO[2,3 C]ISOQUINOLIN 5 ONE; UNCLASSIFIED DRUG;

BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CELL CULTURE; CEREBROVASCULAR ACCIDENT; DNA DAMAGE; DNA STRAND BREAKAGE; DRUG METABOLISM; ENZYME ACTIVITY; GENE DELETION; GENE EXPRESSION; HOMEOSTASIS; HUMAN; IMMUNOREACTIVITY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; RNA INTERFERENCE; TRANSCRIPTION INITIATION;

EID: 19444364781     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2005.02.018     Document Type: Article

References (111)

1. C. Warlow, C. Sudlow, M. Dennis, J. Wardlaw, and P. Sandercock Stroke Lancet 362 2003 1211 1224
2. U. Dirnagl, C. Iadecola, and M.A. Moskowitz Pathobiology of ischaemic stroke: an integrated view Trends Neurosci 22 1999 391 397
3. S. Smith The world according to PARP Trends Biochem Sci 26 2001 174 179
4. L. Davidovich, M. Vodenicharov, E.B. Affar, and G.G. Poirier Importance of poly(ADP-ribose) glycohydrolase in the control of poly(ADP-ribose) metabolism Exp Cell Res 268 2001 7 13
5. D. D'Amours, S. Desnoyers, and G.G. Poirier Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions Biochem J 342 1999 249 268
6. Z. Herceg, and Z.Q. Wang Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death Biochem J 477 2001 97 110
7. C. Szabo, and V.L. Dawson Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion Trends Pharmacol Sci 19 1998 287 298
8. H.C. Ha, and S.H. Snyder Poly(ADP-ribose) polymerase-1 in the nervous system Neurobiol Dis 7 2000 225 239
9. A. Chiarugi PARP-1: killer or conspirator? The suicide hypothesis revisited Trends Pharmacol Sci 23 2002 122 129
10. S.D. Skaper Poly(ADP-Ribose) polymerase-1 in acute neuronal death and inflammation: a strategy for neuroprotection Ann N Y Acad Sci 993 2003 217 228
11. S.A. Lipton, and P.A. Rosenberg Excitatory amino acids as a final common pathway for neurological disorders N Engl J Med 330 1994 613 622
12. D.W. Choi Calcium and excitotoxic neuronal injury Ann N Y Acad Sci 747 1994 162 171
13. Z. Huang, P.L. Huang, N. Panahian, T. Dalkara, M.C. Fishman, and M.A. Moskowitz Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase Science 265 1994 1883 1885
14. C. Iadecola Bright and dark sides of nitric oxide in ischemic brain injury Trends Neurosci 20 1997 132 139
15. L. Giovannelli, A. Cozzi, I. Guarnieri, P. Dolara, and F. Moroni Comet assay as a novel approach for studying DNA damage in focal cerebral ischemia: differential effects of NMDA receptor antagonists and poly(ADP-ribose) polymerase inhibitors J Cereb Blood Flow Metab 22 2002 697 704
16. M. Endres, G. Scott, S. Namura, A.L. Salzman, P.L. Huang, and M.A. Moskowitz Role of peroxynitrite and neuronal nitric oxide synthase in the activation of poly(ADP-ribose) synthetase in a murine model of cerebral ischemia-reperfusion Neurosci Lett 248 1998 41 44
17. T. Tokime, K. Nozaki, T. Sugino, H. Kikuchi, N. Hashimoto, and K. Ueda Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain J Cereb Blood Flow Metab 18 1998 991 997
18. D.E. Pellegrini-Giampietro, G. Cherici, M. Alesiani, V. Carlà, and F. Moroni Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage J Neurosci 10 1990 1035 1041
19. C. Szabo, S. Cuzzocrea, B. Zingarelli, M. O'Connor, and A.L. Salzman Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly(ADP-ribose) synthetase by peroxynitrite J Clin Invest 100 1997 723 735
20. S. Homburg, L. Visochek, N. Moran, F. Dantzer, E. Priel, and E. Asculai A fast signal induced activation of poly(ADP-ribose)polymerase: a downstream target of phospholipase C J Cell Biol 150 2000 293 307
21. T. Nagayama, R.P. Simon, D. Chen, D.C. Henshall, W. Pei, and R.A. Stetler Activation of poly(ADP-ribose) polymerase in the rat hippocampus may contribute to cellular recovery following sublethal transient global ischemia J Neurochem 74 2000 1636 1645
22. R.P. Strosznajder, R. Gadamski, G.A. Czapski, H. Jesko, and J.B. Strosznajder Poly(ADP-ribose) polymerase during reperfusion after transient forebrain ischemia: its role in brain edema and cell death J Mol Neurosci 20 2003 61 72
23. O.P. Mishra, W. Akhter, Q.M. Ashraf, and M. Delivoria-Papadopoulos Hypoxia-induced modification of poly(ADP-ribose) polymerase and DNA polymerase beta activity in cerebral cortical nuclei of newborn piglets: role of nitric oxide Neuroscience 119 2003 1023 1032
24. M.J. Eliasson, K. Sampei, A.S. Mandir, P.D. Hurn, R.J. Traystman, and J. Bao Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia Nat Med 3 1997 1089 1095
25. M. Endres, Z.Q. Wang, S. Namura, C. Waeber, and M.A. Moskowitz Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase J Cereb Blood Flow Metab 17 1997 1143 1151
26. K. Takahashi, A.A. Piper, S.E. Croul, J. Zhang, S.H. Snyder, and J.H. Greenberg Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia Brain Res 829 1999 46 54
27. H. Hagberg, M.A. Wilson, H. Matsushita, C. Zhu, M. Lange, and M. Gustavsson PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury J Neurochem 90 2004 1068 1075
28. S. Ducrocq, N. Benjelloun, M. Plotkine, Y. Ben-Ari, and C. Charriaut-Marlangue Poly(ADP-ribose) synthetase inhibition reduces ischemic injury and inflammation in neonatal rat brain J Neurochem 74 2000 2504 2511
29. L.M. Joly, N. Benjelloun, M. Plotkine, and C. Charriaut-Marlangue Distribution of Poly(ADP-ribosyl)ation and cell death after cerebral ischemia in the neonatal rat Pediatr Res 53 2003 776 782
30. S. Love, R. Barber, and G.K. Wilcock Neuronal death in brain infarcts in man Neuropathol Appl Neurobiol 26 2000 55 66
31. S. Love, R. Barber, and G.K. Wilcock Neuronal accumulation of poly(ADP-ribose) after brain ischaemia Neuropathol Appl Neurobiol 25 1999 98 103
32. C. Cosi, H. Suzuki, D. Milani, L. Facci, M. Menegazzi, and G. Vantini Poly(ADP-ribose) polymerase: early involvement in glutamate-induced neurotoxicity in cultured cerebellar granule cells J Neurosci Res 39 1994 38 46
33. J. Liu, W. Ying, S. Massa, P.J. Duriez, R.A. Swanson, and G.G. Poirier Effects of transient global ischemia and kainate on poly(ADP-ribose) polymerase (PARP) gene expression and proteolytic cleavage in gerbil and rat brains Brain Res Mol 80 2000 7 16
34. C.M. Simbulan-Rosenthal, D.S. Rosenthal, S. Iyer, A.H. Boulares, and M.E. Smulson Transient poly(ADP-ribosyl)ation of nuclear proteins and role of poly(ADP-ribose) polymerase in the early stages of apoptosis J Biol Chem 273 1998 13703 13712
35. V. Schreiber, D. Hunting, C. Trucco, B. Gowans, D. Grunwald, and G. de Murcia A dominant-negative mutant of human poly(ADP-ribose) polymerase affects cell recovery, apoptosis, and sister chromatid exchange following DNA damage Proc Natl Acad Sci 92 1995 4753 4757
36. L. Gan, K.E. Anton, B.A. Masterson, V.A. Vincent, S. Ye, and M. Gonzalez-Zulueta Specific interference with gene expression and gene function mediated by long dsRNA in neural cells J Neurosci Meth 121 2002 151 157
37. G. Costantino, A. Macchiarulo, E. Camaioni, and R. Pellicciari Modeling of poly(ADP-ribose)polymerase (PARP) inhibitors. Docking of ligands and quantitative structure-activity relationship analysis J Med Chem 44 2001 3794
38. G.J. Southan, and C. Szabo Poly(ADP-ribose) polymerase inhibitors Curr Med Chem 10 2003 321 340
39. S. Goto, R. Xue, N. Sugo, M. Sawada, K.K. Blizzard, and M.F. Poitras Poly(ADP-ribose) polymerase impairs early and long-term experimental stroke recovery Stroke 33 2002 1101 1106
40. E.H. Lo, P. Bosque-Hamilton, and W. Meng Inhibition of poly(ADP-ribose) polymerase: reduction of ischemic injury and attenuation of N-methyl-d- aspartate-induced neurotransmitter dysregulation Stroke 29 1998 830 836
41. K. Takahashi, J.H. Greenberg, P. Jackson, K. Maclin, and J. Zhang Neuroprotective effects of inhibiting poly(ADP-ribose) synthetase on focal cerebral ischemia in rats J Cereb Blood Flow Metab 17 1997 1137 1142
42. A. Chiarugi, E. Meli, M. Calvani, R. Picca, R. Baronti, and E. Camaioni Novel isoquinolinone-derived inhibitors of poly(ADP-ribose) polymerase-1: pharmacological characterization and neuroprotective effects in an in vitro model of cerebral ischemia J Pharmacol Exp Ther 305 2003 943 949
43. D. Ferraris, R.P. Ficco, D. Dain, M. Ginski, S. Lautar, and K. Lee-Wisdom Design and synthesis of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. Part 4: biological evaluation of imidazobenzodiazepines as potent PARP-1 inhibitors for treatment of ischemic injuries Bioorg Med Chem 11 2003 3695 3707
44. D. Ferraris, R.P. Ficco, T. Pahutski, S. Lautar, S. Huang, and J. Zhang Design and synthesis of poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors. Part 3: In vitro evaluation of 1,3,4,5-tetrahydro-benzo[c][1,6]- and [c][1,7]-naphthyridin-6-ones Bioorg Med Chem Lett 13 2003 2513 2518
45. D. Ferraris, Y.S. Ko, T. Pahutski, R.P. Ficco, L. Serdyuk, and C. Alemu Design and synthesis of poly ADP-ribose polymerase-1 inhibitors. 2. Biological evaluation of aza-5[H]-phenanthridin-6-ones as potent, aqueous-soluble compounds for the treatment of ischemic injuries J Med Chem 46 2003 3138 3151
46. G.E. Abdelkarim, K. Gertz, C. Harms, J. Katchanov, U. Dirnagl, and C. Szabo Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke Int J Mol Med 7 2001 255 260
47. K. Komjati, J.G. Mabley, L. Virag, G.J. Southan, A.L. Salzman, and C. Szabo Poly(ADP-ribose) polymerase inhibition protect neurons and the white matter and regulates the translocation of apoptosis-inducing factor in stroke Int J Mol Med 13 2004 373 382
48. A. Iwashita, N. Tojo, S. Matsuura, S. Yamazaki, K. Kamijo, and J. Ishida A Novel and Potent Poly(ADP-Ribose) Polymerase-1 Inhibitor, FR247304 (5-Chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazo linone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia J Pharmacol Exp Ther 310 2004 425 436
49. H. Nakajima, N. Kakui, K. Ohkuma, M. Ishikawa, and T. Hasegawa A newly synthesized poly(ADP-ribose) polymerase inhibitor, 2-methyl-3,5,7,8- tetrahydrothiopyrano[4,3-d]pyrimidine-4-one (DR2313): pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats J Pharmacol Exp Ther 2004
50. F. Moroni, E. Meli, F. Peruginelli, A. Chiarugi, A. Cozzi, and R. Picca Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia Cell Death Diff 8 2001 921 932
51. Y. Feng, and M.H. LeBlanc Drug-induced hypothermia begun 5 min after injury with a poly(adenosine 5′-diphosphate-ribose) polymerase inhibitor reduces hypoxic brain injury in rat pups Crit Care Med 30 2002 2420 2424
52. K. Takahashi, and J.H. Greenberg The effect of reperfusion on neuroprotection using an inhibitor of poly(ADP-ribose) polymerase NeuroReport 10 1999 1017 1022
53. Y. Ding, Y. Zhou, Q. Lai, J. Li, V. Gordon, and F.G. Diaz Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment Brain Res 915 2001 210 217
54. M.F. Beal Energetics in the pathogenesis of neurodegenerative diseases Trends Neurosci 23 2000 298 304
55. J.M. Lee, M.C. Grabb, G.J. Zipfel, and D.W. Choi Brain tissue responses to ischemia J Clin Invest 106 2000 723 731
56. P. Lipton Ischemic cell death in brain neurons Physiol Rev 79 1999 1431 1568
57. R.C. Tasker, S.K. Sahota, F.E. Cotter, and S.R. Williams Early postischemic dantrolene-induced amelioration of poly(ADP-ribose) polymerase-related bioenergetic failure in neonatal rat brain slices J Cereb Blood Flow Metab 18 1998 13 46
58. J. Yang, L.K. Klaidman, A. Nalbandian, J. Oliver, M.L. Chang, and P.H. Chan The effects of nicotinamide on energy metabolism following transient focal cerebral ischemia in Wistar rats Neurosci Lett 333 2002 91 94
59. W. Ying, Y. Chen, C.C. Alano, and R.A. Swanson Tricarboxylic acid cycle substrates prevent PARP-mediated death of neurons and astrocytes J Cereb Blood Flow Metab 22 2002 774 779
60. W. Ying, P. Garnier, and R.A. Swanson NAD+ repletion prevents PARP-1-induced glycolytic blockade and cell death in cultured mouse astrocytes Biochem Biophys Res Commun 308 2003 809 813
61. K. Plaschke, J. Kopitz, M.A. Weigand, E. Martin, and H.J. Bardenheuer The neuroprotective effect of cerebral poly(ADP-ribose) polymerase inhibition in a rat model of global ischemia Neurosci Lett 284 2000 109 112
62. W. Paschen, L. Olah, and G. Mies Effect of transient focal ischemia of mouse brain on energy state and NAD levels: no evidence that NAD depletion plays a major role in secondary disturbances of energy metabolism J Neurochem 75 2000 1675 1680
63. L. Klaidman, M. Morales, S. Kem, J. Yang, M.L. Chang, and J.D. Adams Jr. Nicotinamide offers multiple protective mechanisms in stroke as a precursor for NAD+, as a PARP inhibitor and by partial restoration of mitochondrial function Pharmacology 69 2003 150 157
64. M. Ziegler, and S.L. Oei A cellular survival switch: poly(ADP-ribosyl) ation stimulates DNA repair and silences transcription BioEssay 23 2001 543 548
65. W.L. Kraus, and J.T. Lis PARP goes transcription Cell 113 2003 677 683
66. M. Rouleau, R.A. Aubin, and G.G. Poirier Poly(ADP-ribosyl)ated chromatin domains: access granted J Cell Sci 117 2004 815 825
67. S.J. Read, A.A. Parsons, D.C. Harrison, K. Philpott, K. Kabnick, and S. O'Brien Stroke genomics: approaches to identify, validate, and understand ischemic stroke gene expression J Cereb Blood Flow Metab 21 2001 755 778
68. S. Bates, S.J. Read, D.C. Harrison, S. Topp, R. Morrow, and D. Gale Molecular characterization by subtractive hybridization of the Zea Longa model of permanent middle cerebral artery occlusion in the rat. Identification of novel gene expression following experimental ischemia Mol Brain Res 93 2001 70 80
69. E.H. Lo, T. Dalkara, and M.A. Moskowitz Mechanisms, challenges and opportunities in stroke Nat Rev Neurosci 4 2003 399 415
70. F.J. Oliver, J. Menissier-de Murcia, C. Nacci, P. Decker, R. Andriantsitohania, and S. Muller Resistance to endotoxic shock as a consequence of defective NF-kB activation in poly(ADP-ribose) polymerase-1 deficient mice EMBO J 18 1999 4446 4454
71. P.O. Hassa, and M.O. Hottinger A role of poly(ADP-ribose) polymerase in NF-kB transcriptional activation Biol Chem 380 1999 953 959
72. A. Chiarugi, and M.A. Moskowitz Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders J Neurochem 85 2003 306 317
73. P.O. Hassa, and M.O. Hottiger The functional role of poly(ADP-ribose) polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders Cell Mol Life Sci 59 2002 1534 1553
74. A. Chiarugi Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats Br J Pharmacol 137 2002 761 770
75. B. Zingarelli, P.W. Hake, M. O'Connor, A. Denenberg, H.R. Wong, and S. Kong Differential regulation of activator protein-1 and heat shock factor-1 in myocardial ischemia and reperfusion injury: role of poly(ADP-ribose) polymerase-1 Am J Physiol Heart Circ Physiol 286 2004 H1408 H1415
76. H.C. Ha, L.D. Hester, and S.H. Snyder Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia Proc Natl Acad Sci 99 2002 3270 3275
77. J. Wesierska-Gadek, G. Schid, and C. Cerni ADP-ribosylation of wilde-type p53 in vitro: binding of p53 to specific p53-consensus sequence prevents its modification Biochem Biophys Res Commun 224 1996 96 102
78. G. Schmid, Z.Q. Wang, and J. Wesierska-Gadek Compensatory expression of p73 in PARP-deficient mouse fibroblast as response to reduced level of regularly spliced wild-type p53 Biochem Biophys Res Commun 255 1999 399 405
79. J. Wesierska-Gadek, and G. Schmid Overexpressed poly(ADP-ribose) polymerase delays the release of rat cells from p53-mediated G(1) checkpoint J Cell Biochem 80 2000 85 103
80. X. Wang, K. Ohnishi, A. Takahashi, and T. Ohnishi Poly(ADP-ribosyl)ation is required for p53-dependent signal transduction induced by radiation Oncogene 17 1998 2819 2825
81. M.L. Agarwal, A. Agarwal, W.R. Taylor, Z.Q. Wang, E.F. Wagner, and G.R. Stark Defective induction and normal activation and function of p53 in mouse cells lacking poly-ADP-ribose polymerase Oncogene 15 1997 1035 1041
82. G.Z. Feuerstain, X. Wang, and F.C. Barone The role of cytokine in the pathology of stroke and neurotrauma Neuroimmunomodul 5 1998 143 159
83. M.P. Mattson, C. Culmsee, Z. Yu, and S. Camandola Roles of nuclear factor kappaB in neuronal survival and plasticity J Neurochem 74 2000 443 456
84. M.P. Mattson, and S. Camandola NF-kB in neuronal plasticity and neurodegenerative disorders J Clin Invest 107 2001 247 254
85. O. Ullrich, A. Diestel, I.Y. Eyupoglu, and R. Nitsch Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1 Nat Cell Biol 3 2001 1035 1042
86. H. Nakajima, H. Nagaso, N. Kakui, M. Ishikawa, T. Hiranuma, and S. Hoshiko Critical role of the automodification of poly(ADP-ribose) polymerase-1 in nuclear factor-kappaB-dependent gene expression in primary cultured mouse glial cells J Biol Chem 279 2004 42774 42786
87. S.D. Skaper Poly(ADP-ribosyl)ation enzyme-1 as a target for neuroprotection in acute central nervous system injury Curr Drug Targets CNS Neurol Disord 2 2003 279 291
88. S.H. Koh, Y. Park, C.W. Song, J.G. Kim, K. Kim, and J. Kim The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals Eur J Neurosci 20 2004 1461 1472
89. E.M. Park, S. Cho, K. Frys, G. Racchumi, P. Zhou, and J. Anrather Interaction between inducible nitric oxide synthase and poly(ADP-ribose) polymerase in focal ischemic brain injury Stroke 35 2004 2896 2901
90. S.W. Yu, M.F. Poitras, C. Coombs, W.J. Bowers, H.J. Federoff, and G.G. Poirier Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor Science 297 2002 259 263
91. S.W. Yu, H. Wang, T.M. Dawson, and V.L. Dawson Poly(ADP-ribose) polymerase-1 and apoptosis inducing factor in neurotoxicity Neurobiol Dis 14 2003 303 317
92. C. Zhu, L. Qiu, X. Wang, U. Hallin, C. Cande, and G. Kroemer Involvement of apoptosis-inducing factor in neuronal death after hypoxia-ischemia in the neonatal rat brain J Neurochem 86 2003 306 317
93. G. Cao, R.S. Clark, W. Pei, W. Yin, F. Zhang, and F.Y. Sun Translocation of apoptosis-inducing factor in vulnerable neurons after transient cerebral ischemia and in neuronal cultures after oxygen-glucose deprivation J Cereb Blood Flow Metab 23 2003 1137 1150
94. N. Plesnila, C. Zhu, C. Culmsee, M. Groger, M.A. Moskowitz, and K. Blomgren Nuclear translocation of apoptosis-inducing factor after focal cerebral ischemia J Cereb Blood Flow Metab 24 2004 458 466
95. L. Du, X. Zhang, Y.Y. Han, N.A. Burke, P.M. Kochanek, and S.C. Watkins Intra-mitochondrial poly-ADP-ribosylation contributes to NAD+ depletion and cell death induced by oxidative stress J Biol Chem 278 2003 18426 18433
96. A.I. Scovassi Mitochondrial poly(ADP-ribosylation): from old data to new perspectives FASEB J 18 2004 1487 1488
97. M.E. Bonicalzi, M. Vodenicharov, M. Coulombe, J.P. Gagne, and G.G. Poirier Alteration of poly(ADP-ribose) glycohydrolase nucleocytoplasmic shuttling characteristics upon cleavage by apoptotic proteases Biol Cell 95 2003 635 644
98. S. Ohashi, M. Kanai, S. Hanai, F. Uchiumi, H. Maruta, and S. Tanuma Subcellular localization of poly(ADP-ribose) glycohydrolase in mammalian cells Biochem Biophys Res Commun 307 2003 915 921
99. P. Chang, M.K. Jacobson, and T.J. Mitchinson Poly(ADP-ribose is required for spindle assembly and structure Nature 432 2004 645 649
100. S. Hanai, M. Kanai, S. Ohashi, K. Okamoto, M. Yamada, and H. Takahashi Loss of poly(ADP-ribose) glycohydrolase causes progressive neurodegeneration in Drosophila melanogaster Proc Natl Acad Sci U S A 101 2004 82 86
101. S. Di Meglio, M. Denegri, S. Vallefuoco, F. Tramontano, A.I. Scovassi, and P. Quesada Poly(ADPR) polymerase-1 and poly(ADPR) glycohydrolase level and distribution in differentiating rat germinal cells Mol Cell Biochem 248 2003 85 91
102. E.B. Affar, M. Germain, E. Winstall, M. Vodenicharov, R.G. Shah, and G.S. Salvesen Caspase-3-mediated processing of poly(ADP-ribose) glycohydrolase during apoptosis J Biol Chem 276 2001 2935 2942
103. W. Ying, M.B. Sevigny, Y. Chen, and R.A. Swanson Poly(ADP-ribose) glycohydrolase mediates oxidative and excitotoxic neuronal death Proc Natl Acad Sci U S A 98 2001 12227 12232
104. X.C. Lu, E. Massuda, Q. Lin, W. Li, J.H. Li, and J. Zhang Post-treatment with a novel PARG inhibitor reduces infarct in cerebral ischemia in the rat Brain Res 978 2003 99 103
105. U. Cortes, W.M. Tong, D.L. Coyle, M.L. Meyer-Ficca, R.G. Meyer, and V. Petrilli Depletion of the 110 kilodalton isoform of poly(ADP-ribose) glycohydrolase increases sensitivity to genotoxic and endotoxic stress in mice Mol Cell Biol 24 2004 7163 7178
106. E. Rapizzi, S. Fossati, F. Moroni, and A. Chiarugi Inhibition of poly(ADP-ribose) glycohydrolase by gallotannin selectively up-regulates expression of proinflammatory genes Mol Pharmacol 66 2004 890 898
107. Y.J. Tsai, T. Aoki, H. Maruta, H. Abe, H. Sakagami, and T. Hatano Mouse mammary tumor virus gene expression is suppressed by oligomeric ellagitannins, novel inhibitors of poly(ADP-ribose) glycohydrolase J Biol Chem 267 1992 14436 14442
108. S. Panda, G.G. Poirier, and S.A. Kay tej defines a role for poly(ADP-ribosyl)ation in establishing period length of the arabidopsis circadian oscillator Dev Cell 3 2002 51 61
109. V. Schreiber, J.C. Ame, P. Dolle, I. Schultz, B. Rinaldi, and V. Fraulob Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1 J Biol Chem 277 2002 23028 23036
110. W.M. Tong, U. Cortes, and Z.Q. Wang Poly(ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis Biochim Biophys Acta 1552 2001 27 37
111. L. Virag, and C. Szabo The therapeutic potential of poly(ADP-ribose) polymerase inhibitors Pharmacol Rev 54 2002 375 429